2010, Number 3
<< Back Next >>
Anales de Radiología México 2010; 9 (3)
Patients with BI-RADS classification V for image diagnosis of Castleman’s disease and contralateral breast cancer
Cázares AJL, Ríos RN, Quiroz VME
Language: Spanish
References: 10
Page: 137-140
PDF size: 246.44 Kb.
ABSTRACT
Background: Castleman disease is an infrequent disorder characterized by polyclonal hyperplasia of lymphatic ganglia; mostly it is shown located, being benign and with good forecast. Imaging studies are the first tool used to confirm at a later time, the diagnosis through histopathology.
Clinical case: Following, we submitted a case of a 47 years old woman with BI-RADS V report, which developed later counter-lateral breast cancer. It is important to consider excessively the diagnosis of Castleman disease, since it is a pathology whose risk factors are increasing, in addition to that a change in the types of presentation.
REFERENCES
Castleman’s Disease. A Review Bernardino Roca. AIDS Rev 2009; 11: 3-7.
Castleman B, Iverson L, Menedez VP. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer 1956; 9: 822.
Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma-cell types of giant lymph node hyperplasia of the mediastinum and other locations. Cancer 1972; 29: 670.
Yoshizaki K, Matsuda T, Nishimoto N, et al. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in CD. Blood 1989; 74: 1360.
Leger-Ravet MB, Peuchmaur M, Devergne O, et al. Interleukin-6 gene expression in CD. Blood 1991; 78: 2923.
Kikuta H, Itakura O, Taneichi K, Kohno M. Tropism of human herpesvirus 8 for peripheral blood lymphocytes in patients with CD. Br J Haematol 1997; 99: 790.
Luppi M, Barozzi P, Maiorana A, et al. Human herpesvirus-8 DNA sequences in human immunodeficiency virus-negative angioimmunoblastic lymphadenopathy and benign lymphadenopathy with giant germinal center hyperplasia and increased vascularity. Blood 1996; 87: 3903.
Bowne WB, Lewis JJ, Filippa DA, et al. The management of unicentric and multicentric CD: A report of 16 cases and a review of the literature. Cancer 1999; 85: 706.
Herrada J, Cabanillas F, Rice L, Manning J, Pugh W. The clinical behavior of localized and multicentric Castleman Disease. Ann Intern Med 1998; 128: 657-662.
Sobrevilla-Calvo PJ, Avilés-Salas A, Cortés-Padilla DE, Rivas-Vera S. Características clinicopatológicas de la enfermedad de Castleman. Experiencia en el Instituto Nacional de Cancerología. Cir Ciruj 2009; 77: 187-192.
Full text